U.S. needs improved approach to lane drug safety

<p>WASHINGTON (Reuters) – The <span>U.S. Food and Drug Administration</span> should examination drugs on a unchanging basement for as prolonged as they are on a marketplace in sequence to locate any new <span>safety issues</span>, according to a news from an eccentric investigate body.</p>
<p> The Institute of Medicine, that mostly advises a supervision on systematic matters, pronounced a <span>FDA</span> should afterwards emanate a comprehensive, publicly accessible request that reflects risks that stand adult via a “lifecycle” of a drug.</p>
<p> The FDA has been criticized for not fast responding to dangerous side effects that turn some-more clear after a product is brought to market, such as with Vioxx, a painkiller that Merck Co In pulled 5 years after capitulation given of a couple to heart attacks and strokes.</p>
<p> “It’s unfit to know all a risks and advantages...